iBio (IBIO) vs RenovoRx (RNXT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
iBio (IBIO) has outperformed RenovoRx (RNXT) over the past year, gaining 16.1% versus a gain of 12.3%. Over five years, RNXT leads with a -77.1% price change compared with -99.8% for IBIO. RenovoRx is the larger company by market cap ($60.0 million vs $59.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IBIO | RNXT |
|---|---|---|
| Share price | $0.92 | $1.33 |
| Market cap | $59.16M | $60.02M |
| 1-day change | -8.91% | -2.92% |
| YTD return | -47.67% | +63.10% |
| 1-year return | +16.09% | +12.30% |
| 5-year return | -99.78% | -77.09% |
| EPS (TTM) | $-0.32 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.82 | $2.59 |
| 52-week low | $0.78 | $0.701 |
| Distance from 52-week high | -75.92% | -48.65% |
| Average volume | 735.37K | 761.09K |
| Shares outstanding | 64.31M | 45.13M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
IBIO vs RNXT FAQ
Which is bigger, iBio or RenovoRx?
RenovoRx (RNXT) is larger, with a market capitalization of $60.02M compared with $59.16M for iBio (IBIO).
Which stock has performed better over the past year, IBIO or RNXT?
IBIO returned +16.09% over the past 12 months, compared with +12.30% for RNXT (price return, excluding dividends). Past performance does not predict future results.
Are iBio and RenovoRx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.